Page 3 - EndoProxy2012_final

Endo
100 Endo Boulevard
Chadds Ford, PA 19317
610.558.9800
endo.com
endo | AMS Endo Pharmaceuticals HealthTronics Qualitest
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON MAY 23, 2012
Notice is hereby given that the 2012 Annual Meeting of Stockholders of Endo Pharmaceuticals Holdings Inc., a Delaware
corporation, will be held on May 23, 2012 at 10:00 a.m., local time, at our corporate headquarters located at 100 Endo Bou-
levard, Chadds Ford, Pennsylvania 19317.
The purposes of the meeting are:
(1) To elect nine directors, representing all of the members of the Board of Directors of the Company, to serve until
the next Annual Meeting of Stockholders or until their successors are duly elected and qualified;
(2) To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting
firm for the year ending December 31, 2012;
(3) To conduct an advisory vote on the compensation of our named executive officers;
(4) To amend and restate the Company’s Amended and Restated Certificate of Incorporation to change the name of
the Company to Endo Health Solutions Inc.; and
(5) To act upon such other matters as may properly come before the Annual Meeting or any adjournment or postpone-
ment thereof.
Only stockholders of record at the close of business on April 9, 2012 are entitled to notice of and to vote at the 2012 Annual
Meeting and any adjournment thereof.
It is important that your shares be represented and voted at the Annual Meeting. Please vote by MARKING, SIGN-
ING, DATING AND PROMPTLY RETURNING the enclosed proxy card as promptly as possible in the postage-paid
envelope provided so that, whether you intend to be present at the Annual Meeting or not, your shares can be voted.
Returning your proxy card will not limit your rights to attend or vote at the Annual Meeting.
By order of the Board of Directors,
CAROLINE B. MANOGUE
Executive Vice President, Chief Legal Officer & Secretary
Chadds Ford, Pennsylvania
April 27, 2012